Texas Tick-Borne Diseases

Course Overview

Course Outline

1. Introduction 
2. Common Ticks Found in Texas 
3. Tick-Borne Illnesses  
   1. Lyme disease  
   2. Anaplasmosis and Ehrlichiosis 
   3. Spotted fever rickettsiosis 
   4. Tick-borne relapsing fever
   5. Babesiosis
   6. Tularemia 
   7. Heartland (HRTV), Powassan (POWV) and Bourbon (BRBV) 
4. Removal of Ticks 
5. Treatment and Medications for Tick-Borne Diseases 
6. Antibiotics that Inhibit Protein Synthesis 
   1. Tetracyclines 
   2. Doxycycline 
7. Aminoglycosides 
   1. Gentamicin 
   2. Streptomycin 
8. Compound Use of Atovaquone and Azithromycin for Babesiosis 
9. Tick Testing 
10. Prevention and Control 
11. Case Studies 
12. Conclusion

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Texas Tick-Borne Diseases. It will take the average learner 120 minutes to complete and awards 2 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Identify the various types of ticks found in Texas. 
2. Discuss tick-borne illnesses prevalent in Texas, including but not limited to Lyme disease, Rocky Mountain spotted fever, and ehrlichiosis. 
3. List the symptoms, diagnosis methods, and treatment protocols for each tick-borne illness.

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.